Inventor · disambiguated record
Hans-Juergen Woerle
Also filed as: WOERLE HANS-JUERGEN
19 granted patents·59 pending applications·265 citations·filing 2009–2025
95Inventor score
Files withBOEHRINGER INGELHEIM INT68BROEDL ULI CHRISTIAN3DUGI KLAUS3GRAEFE-MODY EVA ULRIKE2JOHANSEN ODD-ERIK1
Top patents by PatentIndex Score
78 records- 0196US11833166B2Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2021·Granted Dec 5, 2023·9 cites·24 claims
- 0296US11666590B2Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2020·Granted Jun 6, 2023·9 cites·32 claims
- 0396US11090323B2Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2019·Granted Aug 17, 2021·17 cites·44 claims
- 0496US10258637B2Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2018·Granted Apr 16, 2019·29 cites·24 claims
- 0596US9949998B2Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2015·Granted Apr 24, 2018·29 cites·12 claims
- 0694US9034883B2Vasoprotective and cardioprotective antidiabetic therapyKLEIN THOMAS·Filed 2011·Granted May 19, 2015·53 cites·5 claims
- 0793US9949997B2Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2015·Granted Apr 24, 2018·27 cites·18 claims
- 0893US9457029B2Treatment of genotyped diabetic patients with DPP-IV inhibitors such as linagliptinDUGI KLAUS·Filed 2010·Granted Oct 4, 2016·29 cites·15 claims
- 0992US8853156B2Treatment for diabetes in patients inappropriate for metformin therapyDUGI KLAUS·Filed 2009·Granted Oct 7, 2014·28 cites·25 claims
- 1091US10034877B2Treatment for diabetes in patients inappropriate for metformin therapyBOEHRINGER INGELHEIM INT·Filed 2016·Granted Jul 31, 2018·11 cites·17 claims
- 1190US11813275B2Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2021·Granted Nov 14, 2023·2 cites·7 claims
- 1290US10092571B2Treatment of genotyped diabetic patients with DPP-IV inhibitors such as linagliptinBOEHRINGER INGELHEIM INT·Filed 2016·Granted Oct 9, 2018·9 cites·9 claims
- 1389US9486526B2Treatment for diabetes in patients inappropriate for metformin therapyDUGI KLAUS·Filed 2014·Granted Nov 8, 2016·11 cites·14 claims
- 1488US2025025470A1Cardio- and renoprotective antidiabetic therapyBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 1587US12427162B2Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2023·Granted Sep 30, 2025·0 cites·16 claims
- 1687US11918596B2Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2021·Granted Mar 5, 2024·1 cites·12 claims
- 1787US2024033270A1Cardio- and renoprotective antidiabetic therapyBOEHRINGER INGELHEIM INT·Filed 2023·Application pending·0 cites
- 1886US11911388B2Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral or non-oral antidiabetic drugBOEHRINGER INGELHEIM INT·Filed 2021·Granted Feb 27, 2024·1 cites·11 claims
- 1986US2025073200A1Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 2083US2024156823A1Vasoprotective and cardioprotective antidiabetic therapyBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 2182US12263153B2Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2022·Granted Apr 1, 2025·0 cites·30 claims
- 2280US12433906B2Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2023·Granted Oct 7, 2025·0 cites·41 claims
- 2380US2022226360A1Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2022·Application pending·0 cites
- 2480US2025312456A1Treatment for diabetes in patients inappropriate for metformin therapyBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 2578US2022088023A1Antidiabetic medicationsBOEHRINGER INGELHEIM INT·Filed 2021·Application pending·0 cites
- 2677US2025082642A1Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral or non-oral antidiabetic drugBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 2776US2021205316A1Cardio- and renoprotective antidiabetic therapyBOEHRINGER INGELHEIM INT·Filed 2021·Application pending·0 cites
- 2876US2022211659A1Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2022·Application pending·0 cites
- 2976US2025241887A1Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2025·Application pending·0 cites
- 3075US2024148737A1Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drugBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 3173US11911387B2Vasoprotective and cardioprotective antidiabetic therapyBOEHRINGER INGELHEIM INT·Filed 2020·Granted Feb 27, 2024·0 cites·3 claims
- 3273US2020338086A1Cardio- and renoprotective antidiabetic therapyBOEHRINGER INGELHEIM INT·Filed 2020·Application pending·0 cites
- 3372US2022323434A1Treatment for diabetes in patients inappropriate for metformin therapyBOEHRINGER INGELHEIM INT·Filed 2022·Application pending·0 cites
- 3472US2018263990A1Cardio- and renoprotective antidiabetic therapyBOEHRINGER INGELHEIM INT·Filed 2018·Application pending·0 cites
- 3572US2024156848A1Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2024·Application pending·0 cites
- 3671US2021228533A1Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2020·Application pending·0 cites
- 3771US2020323861A1Antidiabetic medicationsBOEHRINGER INGELHEIM INT·Filed 2020·Application pending·0 cites
- 3871US2014274889A1Cardio- and renoprotective antidiabetic therapyJOHANSEN ODD-ERIK·Filed 2014·Application pending·0 cites
- 3971US2020138844A1Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2020·Application pending·0 cites
- 4070US2021093633A1Treatment for diabetes in patients inappropriate for metformin therapyBOEHRINGER INGELHEIM INT·Filed 2020·Application pending·0 cites
- 4169US2019192523A1Cardio- and renoprotective antidiabetic therapyBOEHRINGER INGELHEIM INT·Filed 2019·Application pending·0 cites
- 4269US2025345352A1Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2025·Application pending·0 cites
- 4368US2019000855A1Treatment of genotyped diabetic patients with dpp-iv inhibitors such as linagliptinBOEHRINGER INGELHEIM INT·Filed 2018·Application pending·0 cites
- 4468US2018125813A1Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2017·Application pending·0 cites
- 4568US2021059974A1Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2020·Application pending·0 cites
- 4668US2020138770A1Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2020·Application pending·0 cites
- 4767US2019134072A1Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2018·Application pending·0 cites
- 4866US2018344741A1Antidiabetic medicationsBOEHRINGER INGELHEIM INT·Filed 2018·Application pending·0 cites
- 4965US2016089373A1Cardio- and renoprotective antidiabetic therapyBOEHRINGER INGELHEIM INT·Filed 2015·Application pending·0 cites
- 5065US2020360412A1Pharmaceutical composition, methods for treating and uses thereofBOEHRINGER INGELHEIM INT·Filed 2020·Application pending·0 cites
Showing the top 50 of 78 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Hans-Juergen Woerle files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →